Renal response to candoxatrilat in patients with heart failure.

[1]  M. Wilkins,et al.  Effect of endopeptidase‐24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat , 1993, British journal of pharmacology.

[2]  P. Nihoyannopoulos,et al.  Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction. , 1993, British heart journal.

[3]  A. Kenny,et al.  Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. , 1993, The Biochemical journal.

[4]  R. Busse,et al.  Neurohormonal Inhibition and Hemodynamic Unloading During Prolonged Inhibition of ANF Degradation in Patients With Severe Chronic Heart Failure , 1992, Circulation.

[5]  B. Abboa-Offei,et al.  Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats. , 1992, The Journal of pharmacology and experimental therapeutics.

[6]  P. Armstrong,et al.  Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure. , 1992, Journal of cardiovascular pharmacology.

[7]  J. Connell,et al.  Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension , 1992, Journal of hypertension.

[8]  N. Minamino,et al.  Characterization of atrial natriuretic peptide in urine from rats treated with a neutral endopeptidase inhibitor. , 1992, Biochemical and biophysical research communications.

[9]  N. Markandu,et al.  Dietary Sodium and Inhibition of Neutral Endopeptidase 24.11 in Essential Hypertension , 1991, Hypertension.

[10]  H. Imura,et al.  Hemodynamic, Renal, and Hormonal Responses to Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure , 1991, Circulation.

[11]  N. Trippodo,et al.  Heart Failure Augments the Cardiovascular and Renal Effects of Neutral Endopeptidase Inhibition in Rats , 1991, Journal of cardiovascular pharmacology.

[12]  J. Stasch,et al.  Endogenous atrial natriuretic factor is involved in the natriuresis following sodium loading in rats with chronic heart failure. , 1991, Cardiovascular research.

[13]  Cleland Jg.  The renin-angiotensin system in heart failure. , 1991 .

[14]  J. Bennett,et al.  Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodents. , 1991, Clinical science.

[15]  A. Seymour,et al.  Antihypertensive and Renal Activity of SQ 28,603, an Inhibitor of Neutral Endopeptidase , 1991, Journal of cardiovascular pharmacology.

[16]  H. Drexler,et al.  Mechanisms Involved in the Response to Prolonged Infusion of Atrial Natriuretic Factor in Patients With Chronic Heart Failure , 1991, Circulation.

[17]  T. Hedner,et al.  Blunted Renal Response to Atrial Natriuretic Peptide in Congestive Heart Failure Rats Is Reversed by the α2-Adrenergic Agonist Clonidine , 1990, Journal of cardiovascular pharmacology.

[18]  J. Connell,et al.  The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans. , 1990, American Journal of Hypertension.

[19]  P. Needleman,et al.  Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Lehmann,et al.  An endogenous lectin and one of its neuronal glycoprotein ligands are involved in contact guidance of neuron migration. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Peters,et al.  Blood flow measurement from first pass time/activity curves: influence of bolus spreading , 1990 .

[22]  B. Brenner,et al.  Diverse biological actions of atrial natriuretic peptide. , 1990, Physiological reviews.

[23]  K. Margulies,et al.  Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. , 1990, Circulation.

[24]  P. Needleman,et al.  Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation. , 1990, The Journal of clinical investigation.

[25]  H. Hassan.  Induced differentiation of leukaemic cells , 1990, The Lancet.

[26]  P. Merlet,et al.  Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure , 1990, The Lancet.

[27]  M. Zeidel.  Renal actions of atrial natriuretic peptide: regulation of collecting duct sodium and water transport. , 1990, Annual review of physiology.

[28]  T. Münzel,et al.  Sympathoadrenal inhibition by atrial natriuretic peptide is not attenuated during development of congestive heart failure in dogs. , 1989, Circulation.

[29]  S. Goldman,et al.  Atrial natriuretic peptide reverses angiotensin-induced venoconstriction in dogs. , 1989, The American journal of physiology.

[30]  D. Northridge,et al.  EFFECTS OF UK 69 578: A NOVEL ATRIOPEPTIDASE INHIBITOR , 1989, The Lancet.

[31]  O. Munck,et al.  First passage radionuclide cardiography for determination of cardiac output: evaluation of an improved method. , 1989, International journal of cardiology.

[32]  T. Hedner,et al.  Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure. , 1989, Acta physiologica Scandinavica.

[33]  C. Saper,et al.  The biochemical pharmacology of atrial peptides. , 1989, Annual review of pharmacology and toxicology.

[34]  J. Firth,et al.  Renal actions of atrial natriuretic factor. , 1989, Clinical science.

[35]  F. Murad,et al.  Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. , 1988, Journal of the American College of Cardiology.

[36]  E. Schiffrin,et al.  Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure. , 1988, Clinical science.

[37]  S. Bloom,et al.  The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. , 1988, British heart journal.

[38]  A. Peters,et al.  Non-invasive measurement of renal blood flow with 99mTc DTPA: comparison with radiolabelled microspheres. , 1987, Cardiovascular research.

[39]  A M Peters,et al.  Noninvasive measurement of blood flow and extraction fraction. , 1987, Nuclear medicine communications.

[40]  O. Carretero,et al.  Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. , 1987, Kidney international.

[41]  G. Dibona,et al.  Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders. , 1987, The American journal of physiology.

[42]  A. Kenny,et al.  The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11. , 1987, The Biochemical journal.

[43]  G. Macdonald,et al.  Vasoactive intestinal peptide: a direct renal natriuretic substance. , 1987, Clinical science.

[44]  P. Poole‐Wilson,et al.  Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. , 1987, British heart journal.

[45]  Andrew,et al.  Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.

[46]  S. Ball,et al.  Plasma alpha natriuretic peptide in cardiac impairment. , 1986, British medical journal.

[47]  J. Laragh,et al.  Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. , 1986, The American journal of physiology.

[48]  B. W. East,et al.  Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. , 1985, British heart journal.

[49]  N. Gee,et al.  An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues. , 1985, The Biochemical journal.

[50]  J. Laragh,et al.  Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. , 1984, The American journal of medicine.

[51]  S. Bloom,et al.  Measurement of fasting and postprandial plasma VIP in man. , 1978, Gut.

[52]  R. Hamburger,et al.  Tracer microinjection study of renal tubular phosphate reabsorption in the rat. , 1972, The Journal of clinical investigation.

[53]  J. Bröchner-Mortensen.  A simple method for the determination of glomerular filtration rate. , 1972, Scandinavian journal of clinical and laboratory investigation.

[54]  Charles W. Dunnett,et al.  New tables for multiple comparisons with a control. , 1964 .

[55]  F. Plum.  Handbook of Physiology. , 1960 .